线粒体融合蛋白2过表达抑制急性呼吸窘迫综合征肺纤维化及其机制
该研究为体外细胞实验,用5 mg/L LPS刺激人胚肺成纤维细胞(HELF)构建ARDS细胞模型,并以75 mol/L Adv-Mfn2转染过表达Mfn2。结果显示LPS组12-48小时细胞增殖率显著高于空白对照组,过表达Mfn2后各时间点增殖率显著低于LPS组,同时Bcl-2表达下调、caspase-3表达上调。结论提示Mfn2蛋白参与ARDS肺纤维化,机制可能与线粒体介导的抑制细胞增殖有关。
要点
- 体外实验中,5 mg/L LPS刺激后HELF在12-48小时增殖率显著高于空白对照组(如24小时20.09±1.71% vs 1.15±1.12%,P<0.01)。
- 75 mol/L Adv-Mfn2转染过表达Mfn2后,12、24、36、48小时增殖率显著低于LPS组(均P<0.05),如24小时10.52±1.24% vs 20.09±1.71%。
- 过表达Mfn2使Bcl-2蛋白及mRNA表达下调、caspase-3蛋白及mRNA表达上调(均P<0.01)。
- 共聚焦显微镜下过表达Mfn2组凋亡细胞多于LPS组,提示Mfn2可能促进LPS刺激的HELF凋亡。
- 以上均为体外细胞实验结论,尚未在动物模型或临床患者中验证,不能直接作为床旁治疗推荐。
适用人群与场景
- 体外培养的人胚肺成纤维细胞(HELF),以5 mg/L LPS刺激构建ARDS细胞模型;非临床患者研究。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:体外细胞实验;样本量、中心数原文未提及。
- 人群与分组:HELF细胞,分为空白对照组、LPS组(5 mg/L LPS)、Adv-vector+LPS组、Adv-Mfn2+LPS组(75 mol/L Adv-Mfn2转染)。
- 主要结果:LPS组12-48小时增殖率显著高于空白对照组(12小时10.75±1.51% vs 0.73±1.22%,24小时20.09±1.71% vs 1.15±1.12%,36小时20.58±1.55% vs 1.20±1.12%,48小时21.30±1.51% vs 1.23±1.10%,均P<0.01);LPS组与Adv-vector+LPS组无显著差异。
- 过表达Mfn2后12-48小时增殖率显著低于LPS组(12小时8.93±1.14%,24小时10.52±1.24%,36小时10.72±1.30%,48小时10.91±1.20%,均P<0.05)。
- 分子结果:LPS组较空白对照组Bcl-2蛋白(0.68±0.01 vs 0.29±0.01)及mRNA(2.23±0.34 vs 1.00±0.00)升高、caspase-3蛋白(0.37±0.02 vs 0.66±0.02)及mRNA(0.31±0.05 vs 1.00±0.00)降低(均P<0.01);Adv-Mfn2+LPS组较LPS组Bcl-2下调(蛋白0.46±0.01 vs 0.68±0.01;mRNA 1.45±0.14
证据类型、等级与局限
- 证据类型:体外细胞实验(基础研究),非RCT、非临床研究。
- 证据等级或推荐强度:原文未提及。
- 局限:仅为体外HELF细胞实验,样本量未报告,无动物模型及临床验证,不能直接外推至ARDS患者。
对床旁实践的改变
- 该内容为体外机制研究,暂不能改变急诊/ICU对ARDS肺纤维化的具体临床处置。
- 不适用于临床患者抗纤维化治疗决策;Mfn2过表达目前仅为实验性干预,未提及人体剂量、途径或安全性。
- 常见陷阱:不可将细胞增殖率数值误读为临床疗效指标或决策阈值。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To study the inhibitory effect of overexpression of mitofusion 2 (Mfn2) protein on acute respiratory distress syndrome (ARDS) pulmonary fibrosis and its mechanism.
METHODS: Human embryo lung fibroblasts (HELF) were cultured in vitro, and digested and passaged when the adherent rate of HELF reached 80%, and then the cells in good condition were selected for experiment. The ARDS cell model was reproduced by 5 mg/L of lipopolysaccharide (LPS, LPS group); 75 mol/L adenovirus vector carrying mitofusion 2 (Adv-Mfn2) was transfected into HELF (Adv-Mfn2+LPS group); at the same time, blank control group (complete medium culture) and Adv-vector+LPS group were set as controls. The cell proliferation was observed by sulforhodamine B (SRB) method at 0, 12, 24, 36 and 48 hours. After Hoechst 33342 staining, the morphological changes were observed under confocal microscope. Western blotting was used to detect the protein expressions of Bcl-2 and caspase-3. Real-time fluorescence quantitative polymerase chain reaction (RT-qPCR) was used to detect the gene expressions of Bcl-2 and caspase-3.
RESULTS: After LPS stimulation for 12-48 hours, the cell proliferation rates in the LPS group increased gradually, which were significantly higher than those in the blank control group [12 hours: (10.75±1.51)% vs. (0.73±1.22)%, 24 hours: (20.09±1.71)% vs. (1.15±1.12)%, 36 hours: (20.58±1.55)% vs. (1.20±1.12)%, 48 hours: (21.30±1.51)% vs. (1.23±1.10)%, all P < 0.01]. There was no statistically significant difference in the cell proliferation rate between the LPS group and the Adv-vector+LPS group. After overexpression of Mfn2, the cell proliferation rates at 12, 24, 36, 48 hours in the Adv-Mfn2+LPS group were (8.93±1.14)%, (10.52±1.24)%, (10.72±1.30)%, and (10.91±1.20)%, which were significantly lower than those in the LPS group (all P < 0.05). Confocal microscopy showed that some cells in the blank control group had nuclei of different sizes, and some nuclei fragmented or shrank to form apoptotic bodies. The nuclei of the cells in the LPS and Adv-vector+LPS groups were round or oval in size, and only a few apoptotic cells appeared. When Mfn2 was overexpressed, there were more apoptotic cells in the visual field in the Adv-Mfn2+LPS group than LPS group. Western blotting and RT-qPCR results showed that Bcl-2 expressions increased significantly after LPS stimulation in the LPS group as compared with the blank control group [Bcl-2 protein (Bcl-2/GAPDH): 0.68±0.01 vs. 0.29±0.01, Bcl-2 mRNA (2-ΔΔCT): 2.23±0.34 vs. 1.00±0.00, both P < 0.01], and caspase-3 expressions decreased significantly [caspase-3 protein (caspase-3/GAPDH): 0.37±0.02 vs. 0.66±0.02, caspase-3 mRNA (2-ΔΔCT): 0.31±0.05 vs. 1.00±0.00, both P < 0.01]. Compared with LPS group, the expressions of Bcl-2 after overexpression of Mfn2 in the Adv-Mfn2+LPS group were down-regulated [Bcl-2 protein (Bcl-2/GAPDH): 0.46±0.01 vs. 0.68±0.01, Bcl-2 mRNA (2-ΔΔCT): 1.45±0.14 vs. 2.23±0.34, both P < 0.01], and the expressions of caspase-3 were up-regulated [caspase-3 protein (caspase-3/GAPDH): 0.54±0.02 vs. 0.37±0.02, caspase-3 mRNA (2-ΔΔCT): 0.88±0.10 vs. 0.31±0.05, both P < 0.01].
CONCLUSIONS: Mfn2 protein is involved in ARDS pulmonary fibrosis, which may be related to mitochondrial mediated inhibition of cell proliferation.
参考来源
- An N, Zhou X, Zhang X, et al. [Overexpression of mitofusion 2 inhibits acute respiratory distress syndrome pulmonary fibrosis and its mechanism]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34412758. doi:10.3760/cma.j.cn121430-20201222-00768
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。